Cargando…

Head and voice tremor improving with immunotherapy in an anti‐NF155 positive CIDP patient

Chronic inflammatory demyelinating polyradiculoneuropathy with NF155 antibodies (anti‐NF155+) constitutes a specific chronic inflammatory demyelinating polyradiculoneuropathy subset with a high incidence of limb's tremor and poor response to conventional therapies. We report a patient with chro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Painous, Cèlia, López‐Pérez, Mª Ángeles, Illa, Isabel, Querol, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Brief Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899910/ https://www.ncbi.nlm.nih.gov/pubmed/29687027 http://dx.doi.org/10.1002/acn3.539

Ejemplares similares

Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins
por: Querol, Luis, et al.
Publicado: (2015)

Neurofascin (NF)155- and NF186-Specific T Cell Response in a Patient Developing a Central Pontocerebellar Demyelination after 10 Years of CIDP
por: Klehmet, Juliane, et al.
Publicado: (2017)

Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP
por: Querol, Luis, et al.
Publicado: (2021)

Early Head Tremor in Essential Tremor: A Case Series and Commentary
por: Louis, Elan D., et al.
Publicado: (2017)

Terminal complement activation is increased and associated with disease severity in CIDP
por: Quast, Isaak, et al.
Publicado: (2016)

Voice Handicap in Essential Tremor: A Comparison with Normal Controls and Parkinson’s Disease
por: Louis, Elan D., et al.
Publicado: (2013)

Dystonic Head Tremor and the Coexistence of Headache
por: Hulzenga, Marit A., et al.
Publicado: (2017)

Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy
por: Martín-Aguilar, Lorena, et al.
Publicado: (2021)

Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15
por: Martinez-Martinez, Laura, et al.
Publicado: (2017)

IgG4 Valency Modulates the Pathogenicity of Anti–Neurofascin-155 IgG4 in Autoimmune Nodopathy
por: Jentzer, Alexandre, et al.
Publicado: (2022)

The comparison of MRN, electrophysiology and progression among typical CIDP and atypical CIDP subtypes
por: Feng, Yuan, et al.
Publicado: (2020)

Systematic literature review of burden of illness in chronic inflammatory demyelinating polyneuropathy (CIDP)
por: Querol, Luis, et al.
Publicado: (2020)

Serum Contactin-1 in CIDP: A Cross-Sectional Study
por: Wieske, Luuk, et al.
Publicado: (2021)

The Misdiagnosis of CIDP: A Review
por: Allen, Jeffrey A.
Publicado: (2020)

Treatment Approaches for Atypical CIDP
por: Menon, Deepak, et al.
Publicado: (2021)

CIDP: Analysis of Immunomarkers During COVID-19 mRNA-Vaccination and IVIg-Immunomodulation: An Exploratory Study
por: Svačina, Martin K. R., et al.
Publicado: (2023)

Does Raising the Arms Modify Head Tremor Severity in Cervical Dystonia?
por: Cisneros, Elizabeth, et al.
Publicado: (2021)

Repurposing MS immunotherapies for CIDP and other autoimmune neuropathies: unfulfilled promise or efficient strategy?
por: Kohle, Felix, et al.
Publicado: (2023)

Anti-NF155/NF186 IgG4 Antibody Positive Autoimmune Nodopathy
por: Wang, Lijun, et al.
Publicado: (2022)

Case Report: Anti-NF186+ CIDP After Receiving the Inactivated Vaccine for Coronavirus Disease (COVID-19)
por: Wen, Shirui, et al.
Publicado: (2022)

Tremor Associated with Chronic Inflammatory Demyelinating Polyneuropathy and Anti‐Neurofascin‐155 Antibodies
por: Bailly, Laurent, et al.
Publicado: (2018)

Severe CIDP-MGUS responsive to Rituximab
por: Posa, Andreas, et al.
Publicado: (2020)

CIDP mimics: a case series
por: Moshe-Lilie, Orly, et al.
Publicado: (2021)

Restoration of a Conduction Block after the Long-term Treatment of CIDP with Anti-neurofascin 155 Antibodies: Follow-up of a Case over 23 Years
por: Koike, Haruki, et al.
Publicado: (2018)

Isolated Voice Tremor: A Clinical Variant of Essential Tremor or a Distinct Clinical Phenotype?
por: Barkmeier-Kraemer, Julie M.
Publicado: (2020)

MRI biomarkers of proximal nerve injury in CIDP
por: Lichtenstein, Thorsten, et al.
Publicado: (2017)

Progress in Hematopoietic Stem Cell Transplantation for CIDP
por: Qin, Zhen, et al.
Publicado: (2020)

Editorial: Update on the Diagnosis and Management of CIDP Variants
por: Chroni, Elisabeth, et al.
Publicado: (2021)

The neurophysiological lesson from the Italian CIDP database
por: Spina, Emanuele, et al.
Publicado: (2021)

Changes in Midline Tremor and Gait Following Deep Brain Stimulation for Essential Tremor
por: Higuchi, Masa-aki, et al.
Publicado: (2019)

Longitudinal study on nerve ultrasound and corneal confocal microscopy in NF155 paranodopathy
por: Athanasopoulos, Diamantis, et al.
Publicado: (2020)

Suppression of Harmaline Tremor by Activation of an Extrasynaptic GABA(A) Receptor: Implications for Essential Tremor
por: Handforth, Adrian, et al.
Publicado: (2018)

Do Bradykinesia and Tremor Interfere in Voluntary Movement of Essential Tremor Patients? Preliminary Findings
por: Goubault, Etienne, et al.
Publicado: (2017)

A Patient with Neuroferritinopathy Presenting with Juvenile-Onset Voice Tremor
por: Park, Chan Wook, et al.
Publicado: (2020)

Laryngoscopy evaluation protocol for the differentiation of essential and dystonic voice tremor()()
por: de Moraes, Bruno Teixeira, et al.
Publicado: (2015)

Voice Tremor and Botulinum Neurotoxin Therapy: A Contemporary Review
por: Newland, David P., et al.
Publicado: (2022)

The Phenomenology of Primary Orthostatic Tremor
por: Swinnen, Bart E.K.S., et al.
Publicado: (2022)

Deregulated Fcγ receptor expression in patients with CIDP
por: Quast, Isaak, et al.
Publicado: (2015)

CIDP prognosis in patients with IVIG treatment‐related fluctuations
por: Cook, Melissa, et al.
Publicado: (2022)

A Pilot Study of Botulinum Toxin for Jerky, Position-Specific, Upper Limb Action Tremor
por: Saifee, Tabish A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_14fihrnhgvk8k39shclb203u2e